Studies on the first-pass metabolism of ebastine in rats

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 8, 1997, Pages 949-953

  Fujii, Toshihiko ^a   Matsumoto, Satoshi ^a   Hatoyama, Teruo ^a   Miyazaki, Hisashi ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Carebastine; CAS 90729 42 3; CAS 90729 43 4; Ebastine; First pass metabolism; LAS 90

Indexed keywords

ANTIALLERGIC AGENT; EBASTINE;

ANIMAL EXPERIMENT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; INTESTINE; INTRAVENOUS DRUG ADMINISTRATION; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; BUTYROPHENONES; CHROMATOGRAPHY, THIN LAYER; FEMORAL VEIN; HALF-LIFE; HISTAMINE H1 ANTAGONISTS; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIVER; MALE; PIPERIDINES; PORTAL VEIN; RATS; RATS, WISTAR;

EID: 0030741158     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Levander, S., Hagermark, O., Stahle, M., Eur. J. Clin. Pharmacol. 28, 523 (1985)
2. Nicholson, A. N., Stone, B. M., Br. J. Clin. Pharmacol. 13, 199 (1982)
3. Paton, D. M., Webster, D. R., Clin. Pharmacokin. 10, 477 (1985)
4. Berga, P., Puig, J., Fernàndez, A. G. et al., Drugs Today 28 (Suppl. B), 23 (1992)
5. Luria, X., Bakke, O. M., Drugs Today 28 (Suppl. B), 69 (1992)
6. Llenas, J., Bou, J., Massingham, R., Drugs Today 28 (Suppl. B), 29 (1992)
7. Moragees, J., Roberts, D. J., Drugs Future 15, 674 (1990)
8. Wiseman, L. R., Faulds, D., Drugs 51, 260 (1996)
9. Martinez-Tobed, A., Tarrus, E., Segura, J. et al., Drugs Today 28 (Suppl. B), 57 (1992)
10. Vincent, J., Liminana, R., Merendith, P. A. et al., Br. J. Clin. Pharmacol. 26, 497 (1988)
11. Yakuo, I., Ishii, K., Seto, Y. et al., Folia Pharmacol. Jpn. 103, 121 (1994)
12. Fujii, T., Furukawa, H., Yoshida, K. et al., Chemotherapy 32, 117 (1984)
13. Fujii, T., Matsumoto, S., Amejima, H. et al., Arzneim.-Forsch./Drug Res. 44 (I), 527 (1994)
14. Hirayama, H., Morgado, J., Gasinska, I. et al., Drug Metab. Dispos. 18, 588 (1990)
15. Iwamoto, K., Klassen, C. D., J. Pharmacol. Exp. Ther. 203, 365 (1977)
16. Fujii, T., Tanaka, K., Matsumoto, S. et al., Arzneim.-Forsch./Drug Res. 44 (I), 538 (1994)
17. Miyazaki, H., Matsunaga, Y., Nambu, K. et al., Arzneim.-Forsch./Drug Res. 36 (I), 443 (1986)
18. Noordhoek, N., in: Topics in Pharmaceutical Sciences, D. D. Breimer, P. Speiser (eds.), pp. 457-469, Elsevier Science Publishers B.V., New York (1987)
19. George, C. F., Clin. Pharmacokin. 6, 259 (1981)
20. Krishna, D. R., Klotz, U., Clin. Pharmacokin. 26, 144 (1994)
21. Sanderink, G.-J., Martinet, M., Touzet, A. et al., in: Proceedings of The 5th European ISSX Meeting, Tours, France, Sept. 26-29, 1993, pp. 37, ISSX - International Society for the Study of Xenobiotics, Bethesda, Maryland, USA (1993)
22. Stevens, J. C., Berger, P. L., Bordeaux, K. G., in: Proceedings of The 5th European ISSX Meeting, Tours, France, Sept. 26-29, 1993, pp. 66, ISSX - International Society for the Study of Xenobiotics, Bethesa, Maryland, USA (1993)
23. Pang, K. S., Yuen, V., Fayz, S. et al., Drug Metab. Dispos. 14, 102 (1986)
24. Xu, X., Hirayama, H., Pang, K. S., Drug Metab. Dispos. 17, 556 (1989)
25. Hartiala, K., Physiol. Rev. 53, 496 (1973)
26. Wattenberg, L. W., Leong, J. L., Strand, P. J., Cancer Res. 22, 1120 (1962)